Security key
09071M106
- Security type / class
- Equity / SPONSORED ADR
- Total 13F shares
- 42,405
- Total 13F value
- $109,000
- Share change
- -37,556,670
- SEC-reported price per share
- $2.58
- Number of holders
- 2
- Value change
- -$14,236,060
- Number of sells
- 21
Report period
Q3 2019
Institutions
2
Top holders
2
BLRX full security history
Ownership snapshot
Full 13F holder table
BioLineRx Ltd. SEC filings
BioLineRx Ltd. company facts
Broader feeds
Ownership snapshot
Top reported holders of BLRX - BIOLINERX LTD - SPONSORED ADR (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
30 Jun 2019
13F
Highest disclosed value: $9,488,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BVF INC/IL has the largest disclosed position value at $9.49M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BVF INC/IL's linked filing trail.
Disclosed position value
Top 5
BVF INC/IL
$9.49M
Senvest Management, LLC
$2.75M
MORGAN STANLEY
$519K
ORBIMED ADVISORS LLC
$379K
Fosun International Ltd
$263K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BVF INC/IL |
13F
Company
|
—
denominator unverified
|
$9,488,000
25,995,575 shares
|
— | 30 Jun 2019 |
| Senvest Management, LLC |
13F
Company
|
—
denominator unverified
|
$2,752,000
7,538,845 shares
|
— | 30 Jun 2019 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$519,000
1,421,862 shares
|
— | 30 Jun 2019 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$379,000
1,038,600 shares
|
— | 30 Jun 2019 |
| Fosun International Ltd |
13F
Company
|
—
denominator unverified
|
$263,000
730,228 shares
|
— | 30 Jun 2019 |
| Delek Group, Ltd. |
13F
Company
|
—
denominator unverified
|
$134,000
375,047 shares
|
— | 30 Jun 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
42,405
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
22
Q3 2019 holders
2
Holder diff
-20
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 value | Q3 2019 value | Value change | Value Chg % |
|---|